CAS 608141-41-9: Apremilast
Description:Apremilast is a small molecule drug primarily used in the treatment of autoimmune conditions such as psoriasis and psoriatic arthritis. It functions as a selective inhibitor of phosphodiesterase 4 (PDE4), an enzyme that plays a crucial role in the inflammatory response by degrading cyclic adenosine monophosphate (cAMP). By inhibiting PDE4, Apremilast increases intracellular cAMP levels, leading to a reduction in the production of pro-inflammatory cytokines and promoting anti-inflammatory mediators. The substance is characterized by its oral bioavailability and a relatively favorable pharmacokinetic profile, allowing for once-daily dosing. Apremilast is typically well-tolerated, though it may cause gastrointestinal side effects in some patients. Its chemical structure includes a pyrimidine core, contributing to its biological activity. As a therapeutic agent, Apremilast represents a targeted approach to managing chronic inflammatory diseases, offering an alternative to traditional systemic therapies.
Formula:C22H24N2O7S
InChI:InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1
InChI key:InChIKey=IMOZEMNVLZVGJZ-QGZVFWFLSA-N
SMILES:O=C(NC1=CC=CC=2C(=O)N(C(=O)C12)C(C3=CC=C(OC)C(OCC)=C3)CS(=O)(=O)C)C
- Synonyms:
- (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
- (S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide
- Acetamide, N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-
- Cc 10004
- N-[2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide
- N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
- Otezla
- Unii-up7qbp99pn
- Apremilast